Challenges and opportunities of using liquid chromatography and mass spectrometry methods to develop complex vaccine antigens as pharmaceutical dosage forms
Authors:
- 1 October 2016
- journal article
- review article
- Published by Elsevier in Journal of Chromatography B
- Vol. 1032, 23-38
Abstract
No abstract availableKeywords
This publication has 118 references indexed in Scilit:
- Cross-linking and mass spectrometry methodologies to facilitate structural biology: finding a path through the mazeJournal of Structural and Functional Genomics, 2013
- Pandemic influenza vaccine: characterization of A/California/07/2009 (H1N1) recombinant hemagglutinin protein and insights into H1N1 antigen stabilityBMC Biotechnology, 2012
- Prevalence and transmission of hepatitis E virus in domestic swine populations in different European countriesBMC Research Notes, 2012
- Structural basis for lack of toxicity of the diphtheria toxin mutant CRM197Proceedings of the National Academy of Sciences, 2012
- Antigen depot is not required for alum adjuvanticityThe FASEB Journal, 2011
- On the Distribution of Protein Refractive Index IncrementsBiophysical Journal, 2011
- Mammalian Expression of Virus-Like Particles for Advanced Mimicry of Authentic Influenza VirusPLOS ONE, 2010
- A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infectionNature Medicine, 2010
- Evaluation of chemical degradation of a trivalent recombinant protein vaccine against botulinum neurotoxin by LysC peptide mapping and MALDI-TOF mass spectrometryJournal of Pharmaceutical Sciences, 2009
- Phase contrast electron microscopy: development of thin-film phase plates and biological applicationsPhilosophical Transactions of the Royal Society B: Biological Sciences, 2008